Centre Eugène Marquis

corporate_fareorganization

Centre Eugène Marquis

- Funding / Projects
  (44)

44 Projects, page 1 of 9

Prospective construction and validation of a prognostic score to idendify patients who benefit from third-line chemotherapy for metastatic breast cancer in terms of overall survival.
assignment_turned_inProjectPartners:Institut de Cancérologie de l'Ouest, Centre Georges-François Leclerc, Hôpital Morvan, Hôpital de Rangueil, Centre Eugène Marquis +3 partners
Institut de Cancérologie de l'Ouest,
Centre Georges-François Leclerc,
Hôpital Morvan,
Hôpital de Rangueil,
Centre Eugène Marquis,
AMU,
Institut Claudius Regaud,
Institut Curie
Funder: Institut National du Cancer Project Code: INCa-DGOS-3718
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Bevacizumab intra-artériel hépatique et chimiothérapie systémique dans les métastases hépatiques de cancer colorectal métastatasé : étude de phase II multicentrique chez des patients en progression après chimiothérapie systémique de première ligne. Hepatic arterial bevacizumab plus systemic chemotherapy for colorectal liver metastases: a multicenter phase II study in patients resistant to first-line systemic chemotherapy.
assignment_turned_inProjectPartners:Centre Eugène Marquis, ICM-VAL D'AURELLE, Centre Hospitalier Universitaire de Toulouse, Centre René Gauducheau, Institut Gustave Roussy
Centre Eugène Marquis,
ICM-VAL D'AURELLE,
Centre Hospitalier Universitaire de Toulouse,
Centre René Gauducheau,
Institut Gustave Roussy
Funder: Institut National du Cancer Project Code: INCa-DGOS-2444
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
Effect of a tailored program of physical activity and nutritional therapeutic education on clinical, psychological and sociological factors in breast cancer patients undergoing adjuvant treatment : « APAD » multicenter randomized controlled trial
assignment_turned_inProject2012 - 2015Partners:Centre Léon Bérard, Centre Eugène Marquis, CHUG, Hôpital Dupuytren, ICM-VAL D'AURELLE +5 partners
Centre Léon Bérard,
Centre Eugène Marquis,
CHUG,
Hôpital Dupuytren,
ICM-VAL D'AURELLE,
Institut Sainte Catherine,
Centre Oscar Lambret,
Centre Jean Perrin,
Université Montpellier,
Centre René Gauducheau
Funder: Institut National du Cancer Project Code: INCa-6162
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
A randomized, open label, multicenter, comparative phase II trial of Ipilimumab after isolated limb perfusion (ILP) , in patients with in-transit metastases melanoma stage IIIB and IIIC
assignment_turned_inProjectPartners:Délégation à la Recherche et à lInnovation - CHU Angers, Hôpital Saint-Louis, Centre Hospitalier Régional et Universitaire de Lille, Institut Gustave Roussy, Hôpital Purpan +3 partners
Délégation à la Recherche et à lInnovation - CHU Angers,
Hôpital Saint-Louis,
Centre Hospitalier Régional et Universitaire de Lille,
Institut Gustave Roussy,
Hôpital Purpan,
Institut Claudius Regaud,
Centre Eugène Marquis,
Hôpital Saint André
Funder: Institut National du Cancer Project Code: INCa-DGOS-5549
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
GETUG-AFU 25/PEACE 3: Personalized treatment of patients with metastatic castrate-resistant prostate cancer (MCRPC) receiving docetaxel, using either early switch to cabazitaxel or maintenance treatment with docetaxel plus radium-223, based on circulating tumor cell (CTCs) enumeration.
assignment_turned_inProjectPartners:Centre François Baclesse, Institut Curie, Centre Eugène Marquis, Centre René Gauducheau, Institut Paoli-Calmettes- (IPC) +10 partners
Centre François Baclesse,
Institut Curie,
Centre Eugène Marquis,
Centre René Gauducheau,
Institut Paoli-Calmettes- (IPC),
Centre Hospitalier de Mont-de-Marsan,
Centre Antoine Lacassagne,
Clinique Sainte Marguerite,
Centre Léon Bérard,
Hôpital Saint-Louis,
Institut Jean Godinot,
Hôpital Saint Joseph,
Hôpital Édouard Herriot,
Institut Gustave Roussy,
Institut de Cancérologie de l'Ouest
Funder: Institut National du Cancer Project Code: INCa-DGOS-7193
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

chevron_left
1
2
3
4
5
chevron_right

Centre Eugène Marquis

Centre Eugène Marquis

44 Projects, page 1 of 9

Prospective construction and validation of a prognostic score to idendify patients who benefit from third-line chemotherapy for metastatic breast cancer in terms of overall survival.

Effect of a tailored program of physical activity and nutritional therapeutic education on clinical, psychological and sociological factors in breast cancer patients undergoing adjuvant treatment : « APAD » multicenter randomized controlled trial

A randomized, open label, multicenter, comparative phase II trial of Ipilimumab after isolated limb perfusion (ILP) , in patients with in-transit metastases melanoma stage IIIB and IIIC

GETUG-AFU 25/PEACE 3: Personalized treatment of patients with metastatic castrate-resistant prostate cancer (MCRPC) receiving docetaxel, using either early switch to cabazitaxel or maintenance treatment with docetaxel plus radium-223, based on circulating tumor cell (CTCs) enumeration.

Loading